Does Including Egfr Along To Hba1C As A Driver Of Treatment Switch Changes Outcomes In Cost-Effectiveness Analyses In Type 2 Diabetes?

AuthID
 P-00T-FV1
2
Author(s)
Lamotte, M
Document Type
Abstract
Year published
2020
Published
in VALUE IN HEALTH, ISSN: 1098-3015
Volume: 23, Pages: S516-S517 (2)
Indexing
Wos®
Publication Identifiers
Wos: WOS:000614644000533
Source Identifiers
ISSN: 1098-3015
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service